Assignee
GRAYBUG VISION INC
US·13 granted patents·10 pending applications·16 citations·filing 2016–2023
Top patents by PatentIndex Score
23 records- 0187US9808531B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2016·Granted Nov 7, 2017·5 cites·27 claims
- 0281US9956302B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted May 1, 2018·2 cites·50 claims
- 0379US11160870B2Extended release microparticles and suspensions thereof for medical therapyGRAYBUG VISION INC·Filed 2018·Granted Nov 2, 2021·1 cites·57 claims
- 0478US10159747B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted Dec 25, 2018·1 cites·49 claims
- 0578US10117950B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted Nov 6, 2018·1 cites·48 claims
- 0678US10111964B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted Oct 30, 2018·1 cites·37 claims
- 0778US10098965B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2017·Granted Oct 16, 2018·1 cites·47 claims
- 0877US11407781B2Equatorially modified polymer linked multimers of guanosine-3′, 5′-cyclic monophosphatesGRAYBUG VISION INC·Filed 2017·Granted Aug 9, 2022·2 cites·15 claims
- 0977US2024041783A1Aggregating microparticles for medical therapyGRAYBUG VISION INC·Filed 2023·Application pending·0 cites
- 1076US11331276B2Aggregating microparticles for medical therapyGRAYBUG VISION INC·Filed 2019·Granted May 17, 2022·1 cites·35 claims
- 1174US11564890B2Aggregating microparticles for medical therapyGRAYBUG VISION INC·Filed 2019·Granted Jan 31, 2023·0 cites·59 claims
- 1273US10441548B2Aggregating microparticles for medical therapyGRAYBUG VISION INC·Filed 2016·Granted Oct 15, 2019·1 cites·78 claims
- 1370US2024092745A1Drugs and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2023·Application pending·0 cites
- 1469US2023058971A1Extended release microparticles and suspensions thereof for medical therapyGRAYBUG VISION INC·Filed 2021·Application pending·0 cites
- 1569US2023056284A1Extended release microparticles and suspensions thereof for medical therapyGRAYBUG VISION INC·Filed 2021·Application pending·0 cites
- 1668US11548861B2Drugs and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2019·Granted Jan 10, 2023·0 cites·11 claims
- 1767US10485876B2Compounds and compositions for the treatment of ocular disordersGRAYBUG VISION INC·Filed 2018·Granted Nov 26, 2019·0 cites·34 claims
- 1862US2020230246A1Extended release microparticles and suspensions thereof for medical therapyGRAYBUG VISION INC·Filed 2020·Application pending·0 cites
- 1954US2021040111A1Drugs to treat ocular disordersGRAYBUG VISION INC·Filed 2020·Application pending·0 cites
- 2054US2021214374A1Compounds and compositions for ocular deliveryGRAYBUG VISION INC·Filed 2021·Application pending·0 cites
- 2151US2020308162A1Drugs and compositions for ocular deliveryGRAYBUG VISION INC·Filed 2020·Application pending·0 cites
- 2251US2021085607A1Continuous microparticle manufactureGRAYBUG VISION INC·Filed 2020·Application pending·0 cites
- 2350US2021275456A1Aggregated microparticlesGRAYBUG VISION INC·Filed 2021·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →